# Appco Pharma LLC – FDA Inspection, Mar 11, 2024

Source: https://www.keypedia.com/records/fda_inspections/appco-pharma-llc/b847f1fe-c466-48a8-8cad-d077d6a1104d
Source feed: FDA_Inspections

> FDA inspection 1232512 of Appco Pharma LLC, March 11, 2024. Classification: Voluntary Action Indicated (VAI). 2 citations under 21 CFR part 314. 9 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1232512
- Company Name: Appco Pharma LLC
- Inspection Date: 2024-03-11
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Postmarket Surv. and Epidemiology
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 2

## Related Documents

- [FDA Inspection 1301504 - 2026-05-14](https://www.keypedia.com/records/fda_inspections/appco-pharma-llc/70fc121e-d60a-4e25-8d7e-ed5942f9a4f0)
- [FDA Inspection 1216223 - 2023-08-29](https://www.keypedia.com/records/fda_inspections/appco-pharma-llc/773429a4-2a26-471f-8bf2-77c3a2f2fdef)
- FDA Inspection 1179037 - 2022-08-19
- FDA Inspection 1122406 - 2020-03-27
- FDA Inspection 1093238 - 2019-05-28

## Related Officers

- [Company Rep](https://www.keypedia.com/people/tyanna-n-hadley/8fdebfd7-d6f3-44ab-9dcb-864ab6d55d53)

Company: https://www.keypedia.com/companies/appco-pharma-llc/b4a77ba5-0e8a-47ae-94c2-951f5a0b2100

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c
